Filing Details

Accession Number:
0001104659-21-057674
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-29 16:31:40
Reporting Period:
2020-05-22
Accepted Time:
2021-04-29 16:31:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1680048 Mustang Bio Inc. MBIO Pharmaceutical Preparations (2834) 473828760
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709485 Md Manuel Litchman 377 Plantation Street
Worcester MA 01605
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-22 4,025 $3.04 821,383 No 4 S Direct
Common Stock Disposition 2020-05-22 8,348 $3.04 813,035 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. 4,025 shares were sold in connection with the vesting of 15,250 shares on March 26, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  2. 8,348 shares were sold in connection with the vesting of 30,500 shares on April 24, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  3. Represents the weighted average sales price.
  4. Includes restricted share units, which vest over various time periods.